Lisinopril

Overview

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily in the treatment of high blood pressure and heart failure. It helps to relax blood vessels, making it easier for the heart to pump blood.

API suppliers (16)

Suppliers of Lisinopril evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• UNIMARK REMEDIES LTDIndia1 active DMF
• EVONIK OPERATIONS GMBHGermany1 active DMF GMP on record
• Zhejiang Changming Pharmaceutical Co.,LtdChina1 active DMF
• Emcure Pharmaceuticals LimitedIndia1 active DMF GMP on record
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• Lupin LimitedIndia1 active DMF GMP on record
• Hetero Drugs LimitedIndia1 active DMF GMP on record
• ZENECA PHARMACEUTICALS
• FARMHISPANIA SASpain
• Ipca Laboratories LimitedIndia GMP on record
• Aurobindo Pharma UsaUnited Kingdom
• MYLAN LABORATORIES LTD GMP on record
• Gedeon Richter Usa
• ESTEVE QUIMICA SA GMP on record
• Sun Pharmaceutical Industries LimitedIndia GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (79 approved US products), the latest listed US patent on Lisinopril expires 6 Nov 2035. Generic API sourcing typically opens up once these lapse.

Therapeutic areas